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Aims ‘Functional foods’ supplemented with plant sterol esters (PSE) and plant stanol esters (PSA) are therapeutic options
for the management of hypercholesterolaemia. However, their effects on blood monocytes, endothelial function,
atherogenesis, and sterol tissue concentrations are poorly understood.
Methods
and results
Male apoE2/2 mice (n ¼ 30) were randomized to three different diets for 6 weeks (n ¼ 10 per group): high-choles-
terol (1.25%) western-type diet (WTD), WTD + 2% PSE, and WTD + 2% PSA. Both supplements reduced serum
cholesterol. WTD + PSE resulted in increased plant sterol serum concentrations and increased inflammatory
Ly-6C(high) monocyte numbers. WTD + PSA increased plant stanol serum concentrations and Ly-6C-monocyte
numbers, but decreased vascular superoxide release, lipid hydroperoxides, and inflammatory cytokines in aortic
tissue, in plasma, and in circulating monocytes. Despite reduced serum cholesterol concentrations, both supplements
impaired endothelial vasodilation compared with WTD. WTD + PSA reduced the development of atherosclerotic
lesions compared with WTD alone (12.7+ 3.7 vs. 28.3+ 3.5%), and WTD + PSE was less effective
(17.5+3.7%). WTD + PSE and WTD + PSA reduced the cholesterol content in the liver, but not in the brain.
However, WTD + PSE and WTD + PSA increased plant sterol and plant stanol concentrations in the liver as
well as in the brain.
Conclusion PSE and PSA supplementation reduced serum cholesterol, but increased plant sterol and plant stanol concentrations.
Elevated levels of PSE and PSA were associated with endothelial dysfunction and increased central nervous system
depositions. Atherosclerotic lesion retardation was more pronounced in WTD + PSA, coinciding with higher regen-
erative monocyte numbers, decreased oxidative stress, and decreased inflammatory cytokines compared with
WTD + PSE.
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1. Introduction
Hypercholesterolaemia is a major risk factor for cardiovascular dis-
eases.1 An important strategy in the reduction of cardiovascular risk
includes a healthy diet and lifestyle.2 ‘Functional foods’ supplemented
with plant sterol esters (PSE) and plant stanol esters (PSA) are widely
used as a ‘non-prescription’ approach to lower plasma cholesterol
levels.2,3 However, recently released guidelines are more critical of
food supplementation with phytosterols and draw attention to poten-
tial safety issues.4,5 Phytosterols are plant-derived non-nutritive com-
pounds whose chemical structure differs from that of cholesterol only
by minor modifications.6 Sitosterol and campesterol are the most fre-
quently occurring phytosterols in food (60 and 35%, respectively).
Plant stanols, on the other hand, are the less abundant saturated
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form of plant sterols. Estimates for intestinal absorption of plant
sterols range from 0.4 to 5% and from 0.02 to 0.3% for their saturated
counterparts. Consequently, plant stanol concentrations in serum are
much lower than plant sterol concentrations. In humans, daily phytos-
terol doses ranging from 0.8 to 4.0 g have been shown to reduce
LDL-cholesterol concentrations by 10–15%.3 Their primary mechan-
ism of lowering blood cholesterol levels is the competitive replace-
ment of cholesterol in bile salt micelles, resulting in reduced
absorption of unesterified cholesterol from the small intestine.3,6
The precise molecular mechanisms for sterol absorption are not
well defined, but absorption of both cholesterol and phytosterol is
known to require the NPC1L1 protein. The majority of absorbed
phytosterols are excreted by the liver, but small amounts are
retained.6 The biological significance of increased plasma and tissue
sterol and stanol concentrations induced by phytosterol-enriched
food remains a matter of controversial debate.6 –9 Moreover, a
recently published clinical trial demonstrated a negative effect on
the microcirculation induced by a diet supplementation with PSE,
but not by PSA in statin-treated humans with mild hyercholsterolae-
mia.10 On this background and based on differences in chemical struc-
ture and metabolism, we hypothesized that inhibition of plasma
cholesterol levels in apoE2/2 mice by PSE and PSA has differential
effects on blood monocytes, lymphocytes, oxidative stress, inflamma-
tory cytokines, endothelial function, and atherogenesis and may differ-
entially affect sterol concentrations in the liver and brain.
2. Methods
2.1 Animals and diets
Male apoE2/2 mice (C57/BL6 background, 8–12 weeks of age, 20–25 g)
were purchased from Charles River, Sulzfeld, Germany, and maintained in
a specific pathogen-free environment on a 12 h light/12 h dark cycle. The
investigation conformed with the Guide for the Care and Use of Labora-
tory Animals published by the US National Institutes of Heath (NIH
Publication No. 85-23, revised 1996) and was approved by the Ethics
Committee of the University of the Saarland. After 1 week of adaptation,
30 mice were randomized to three treatment groups matched for body
weight. All three groups were fed a ‘western-type’ diet [WTD; 40 kcal%
butterfat, 1.25% (w/w) cholesterol]. One group (n ¼ 10) was fed a diet
supplemented with 3.4% PSE (w/w) (WTD + PSE), and the second
group was fed a diet supplemented with 3.4% PSA (w/w) (WTD +
PSA). Mice fed the standard WTD without supplementation were used
as controls (WTD). PSE and PSA were obtained from the RAISIO
company (Turku, Finland). Approximately 40% (w/w) of the PSE and
PSA were rapeseed oil fatty acids, and to maintain comparable fatty acid
profiles and energy contents, 1.4% rapeseed oil was added to control
WTD-fed animals. Over the 6-week study period, mice had ad libitum
access to water and were subjected to restricted feeding of 3 g per day.
Food consumption was monitored throughout the total experimental
period. Diets were prepared by the SNIFF company (Soest, Germany).
Lipid and sterol content of the diets were controlled by gas–liquid chrom-
atography–mass spectrometry during the course of the study.
2.2 Measurement of sterol concentrations in
the plasma, liver, and brain
Blood samples and tissues were immediately centrifuged, and plasma was
stored at 2708C. For sterol quantifications, tissue samples were frozen to
dryness using a vacuum and subjected to chloroform/methanol extraction
for 2 days. Analyses of cholesterol, lathosterol, sitosterol, and campesterol
were performed by gas–liquid chromatography–mass spectrometry as
described.11
2.3 Evaluation of effects of PSE and PSA on
peripheral blood mononuclear cells
Mouse leucocytes were characterized by flow cytometry using
anti-CD115 (AbD Serotec, Du¨sseldorf, Germany), -CD11b, and -Ly-6C
staining (BD Biosciences, Heidelberg, Germany). Monocytes were ident-
ified in the SSC/CD11b dot blot by granularity and high expression of
CD11b. According to this gating strategy, three monocyte subsets
were identified: CD115 + CD11b + Ly-6C++ [termed Ly-6C(high)],
CD115 + CD11b + Ly-6C+ [termed Ly-6C(low)], and CD115 +
CD11b + Ly-6C2 (termed Ly-6C2). Although our study was not
designed to analyse various lymphocyte subsets, our staining protocol
allowed characterization of the CD11b-Ly-6C+ lymphocyte subset,
which may be composed of CD4- and CD8-positive lymphocytes.
Blood smear analysis was performed to determine absolute cell
numbers; to calculate the absolute lymphocyte/monocyte numbers per
microlitre of blood, leucocyte frequencies were related to the blood
smear analysis. Pappenheim staining was performed followed by micro-
scopic analysis for differentiation of the cellular blood components. For
flow cytometric analysis, 50 mL of heparinized blood was first washed
with FACS buffer [PBS supplemented with 5% foetal calf serum
(Seromed, Berlin, Germany) and 0.5% bovine serum albumin (Serva, Hei-
delberg, Germany)]. Cells were stained for 20 min at 48C, followed by a
10 min incubation in lysing buffer (0.83% NH4Cl, 0.1% KCO3, 0.1 mM
EDTA-Na4, pH 7.2). After washing the cells, leucocytes were fixed in
1% paraformaldehyde and stored at 48C until FACS analysis (FACSCali-
bur, BD Biosciences).
2.4 Measurement of vascular superoxide
production and lipid peroxidation
Superoxide release in intact aortic segments was determined by L-012
chemiluminescence and lipid hydroperoxides were determined with
Lipid Peroxidation Assay Kit II (Calbiochem, Gibbstown, NJ, USA) and
expressed as percentage to controls (WTD) as described.12 NADPH
oxidase activity was measured by a lucigenin-enhanced chemilumines-
cence assay.12
2.5 Measurement of inflammatory cytokines
in aortic tissue
mRNA expression in the aorta was assessed by real-time RT–PCR of
mmIL-6, mmMCP-1, mmICAM, mmVCAM, and mmTNF-a. Data were
analysed in a semi-quantitative fashion and expressed relative to 18S
rRNA expression levels.
2.6 Measurement of inflammatory cytokines
in plasma
Inflammatory cytokines (TNF-a, MCP1, IL-6, IL-10, IL-12, and
interferon-g) were measured in the plasma of apoE2/2 mice by a flow
cytometry-based cytokine bead array according to the manufacturer’s
instructions (BD Biosciences).
2.7 Measurement of inflammatory cytokines
in monocytes
Blood was collected and mononuclear cells were isolated using Ficollw
density gradient centrifugation. Real-time RT–PCR was performed for
mmIL-6, mmIL1b, and mmMCP-1.
O. Weinga¨rtner et al.Page 2 of 9
 at Saarlaendische Universitaets-uLandesbibliothek/ M







2.8 Aortic ring preparations and tension
recording
Two millimetre rings of the descending aorta were mounted in organ
baths to record isometric tension and assess endothelial-dependent and
-independent function as described previously.12
2.9 Staining of atherosclerotic lesions and
morphometric analysis
Hearts with the ascending aorta were embedded in Tissue Tek O.C.T.
embedding medium (Miles) as described previously.13 Macrophages were
detected by immunostaining with MOMA-2, 1:50 (Serotec MCA519G,
Oxford, UK), followed by Alexa Flour, 1:200, 546 (Invitrogen);
Ly-6C-positive macrophages were detected by immunostaining with
Ly-6C, 1:600 (BD Pharmingen, Franklin Lakes, USA). For smooth muscle
cell (SMC) a-actin staining, monoclonal anti-a-smooth muscle actin,
1:500 (Sigma), was applied. For morphometric analysis, haematoxylin stain-
ing was performed according to the standard protocols.13 All sections were
examined under a Nikon E 600 microscope. Lucia Measurement Version
4.6 software was used to measure the area of histological sections.
2.10 Statistical analysis
Data are reported as mean+ SEM. Differences between experimental
groups were analysed by one-way ANOVA followed by application of
the Bonferroni test. P-values ,0.05 were considered as statistically
significant. All statistical tests were performed using SPSS software
(Chicago, IL, USA).
3. Results
3.1 Effects of PSE and PSA on plasma sterol
concentrations
Three groups of apoE2/2 mice were each fed specific diets for 6
weeks and plasma lipids and lipoprotein profiles were determined.
The average plasma cholesterol level in the group fed the WTD
was 932+55 mg/dL. Supplementation with PSA reduced plasma
cholesterol levels by 29% (to 661+ 68 mg/dL), whereas PSE sup-
plementation caused a 43% reduction (to 530+ 69 mg/dL)
(Figure 1A). Dietary supplementation with PSE increased plasma
plant sterol concentrations compared with levels in control
WTD-fed animals (13.46+ 1.83 vs. 0.58+0.07 mg/dL for campes-
terol; P, 0.0005) (Figure 1C). In contrast, supplementation with
PSA showed a reduction in plasma plant sterol concentrations;
however, this effect did not reach statistical significance (0.33+
0.06 vs. 0.58+ 0.07 mg/dL for campesterol). Dietary supplementation
with PSA increased plasma plant stanol concentrations compared with
levels detected in control animals fed the WTD (532+28 vs. 7.8+
2.0 mg/dL for campestanol; P, 0.0005) (Figure 1B).
3.2 Effects of PSE and PSA on peripheral
blood mononuclear cells
Although no difference in absolute numbers of leucocytes per microli-
tre blood was observed among the three groups (WTD: 3355.0+
215.3, WTD + PSA: 3405.7+ 278.0, WTD + PSE: 3483.7+345.4;
P ¼ 0.95), there was a trend for higher lymphocyte numbers in
PSA-fed mice (WTD: 1849.0+ 161.5, WTD + PSA: 2186.6+176.2,
WTD + PSE: 1859.2+215.1; P ¼ 0.36) and higher monocyte
numbers in PSE-fed mice (WTD: 311.0+38.9, WTD + PSA:
329.1+ 30.8, WTD + PSE: 415.6+ 42.1; P ¼ 0.13). By flow cytome-
try, the heterogeneous monocytes can be divided into three monocyte
subsets (see Section 2): the ‘inflammatory’ subset is defined by high
expression of Ly-6C [Ly-6C(high)] and two so-called ‘patrolling’ sub-
populations characterized either by weak positive staining
[Ly-6C(low)] or by negative staining for the Ly-6C antigen (Ly-6C2)
respectively. As depicted in Figure 2A in the apoE knockout model, sup-
plementation with sterol esters increased the inflammatory
Ly-6C(high) monocyte subset in comparison to the other diets
(WTD: 74.8+ 13.7, WTD + PSA: 73.6.0+9.9, WTD + PSE:
138.0+ 21.2; P ¼ 0.01). Elevated numbers of the Ly-6C(low) subpopu-
lation were measured for animals supplemented with PSE, but this
difference did not reach statistical significance (WTD: 175.8+38.7,
WTD + PSA: 149.0+32.2, WTD + PSE: 234.5+42.0; P ¼ 0.28). In
Figure 1 Effects of dietary PSA and PSE on plasma cholesterol,
campestanol, and campesterol. ApoE2/2 mice were fed a high-
cholesterol WTD supplemented with PSA or PSE, and plasma
cholesterol (A), campestanol (B), and campesterol (C ) concen-
trations were determined by gas– liquid chromatography–mass
spectrometry. Values are mean+ SEM (n ¼ 10 per group).
*P, 0.05 for WTD + PSE vs. WTD, WTD + PSA vs. WTD.
#P, 0.05 for WTD + PSA vs. WTD and WTD + PSE. §P, 0.05
for WTD + PSE vs. WTD and WTD + PSA.
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contrast, Ly-6C2 monocytes, which may be composed of both ‘patrol-
ling’ monocytes and haematopoietic progenitor cells, were about twice
as high in PSA-fed mice in comparison to PSE-fed mice (WTD: 60.4+
14.3, WTD + PSA: 106.5+ 21.7, WTD + PSE: 43.2+13.1; P ¼ 0.04)
(Figure 2B). Additionally, the former animal group also showed elevated
CD115-CD11b-Ly-6C+ lymphocytes numbers (Figure 2C).
3.3 Effects of plant sterols and plant stanols
on vascular superoxide production,
NADPH activity, and lipid hydroperoxides
As shown in Figure 3A, vascular superoxide release was significantly
decreased in mice on the diet supplemented with PSA compared
with those supplemented with PSE. Furthermore, lipid hydroperox-
ides were significantly decreased in mice on a diet supplemented
with PSA compared with WTD and WTD + PSE (Figure 3B).
However, no difference in NADPH activity was observed among
the WTD (188+26%), WTD + PSA (216+48%), and WTD +
PSE (225+65%) groups.
3.4 Effects of plant sterols and plant stanols
on inflammatory cytokines in aortic tissue,
in plasma, and in monocytes
As depicted in Figure 4A, mice on WTD + PSA showed a significant
reduction in IL-6 mRNA expression in aortic tissue compared with
WTD and WTD + PSE. There were no significant differences in
mRNA expression of MCP-1, ICAM, VCAM, and TNF-a between the
treatment groups (data not shown). As depicted in Figure 4B, mice on
WTD + PSA showed a significant reduction in TNF-a serum levels,
whereas a diet supplement with PSE resulted in a less pronounced
reduction in TNF-a serum levels. Furthermore, we observed a more
Figure 2 Effects of dietary PSA and PSE on circulating peripheral
blood mononuclear cells. Effects of 6 weeks of treatment of
apoE2/2 mice with a high-cholesterol WTD supplemented with
PSA or PSE. Values are mean+ SEM (n ¼ 10 per group). (A)
Effect on circulating inflammatory CD115 + CD11b + Ly6C(high)
monocytes. *P, 0.05 for WTD + PSE vs. WTD + PSA, #P, 0.05
for WTD + PSE vs. WTD. (B) Effect on circulating ‘patrolling’
CD115 + CD11b + Ly-6C-monocytes. *P, 0.05 for WTD + PSE
vs. WTD + PSA. (C) Effect on circulating lymphocytes. #P, 0.05
for WTD + PSA vs. WTD and WTD + PSE.
Figure 3 Effects of dietary PSA and PSE on vascular oxidative
stress. Parameters of vascular oxidative stress were assessed in
WTD-, WTD + PSA-, and WTD + PSE-fed mice. Values are
mean+ SEM (n ¼ 6–7 per group). (A) Superoxide production in
intact aortic ring preparations was assessed by L-012 chemilumines-
cence. *P, 0.05 for WTD + PSA vs. WTD and WTD + PSE. (B)
Concentrations of lipid hydroperoxides in aortic homogenates.
#P, 0.05 for WTD + PSA vs. WTD and WTD + PSE.
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pronounced reduction in IL-6 serum levels in animals on a diet sup-
plement with PSA compared with those on PSE (Figure 4C). However,
this effect did not reach statistical significance (P ¼ 0.07). We did not
observe any differences in regard to serum levels of MCP-1, IL-10,
IL-12, and interferon-g in WTD-, WTD + PSA-, and WTD +
PSE-fed animals (data not shown). As depicted in Figure 4D, mice on
WTD + PSA showed a reduced expression of IL-6 in circulating mono-
cytes compared with WTD. Again, this reduction was less pronounced
in WTD + PSE-fed animals. Furthermore, we observed a more pro-
nounced reduction in IL-1b and MCP-1 in WTD + PSA-fed animals
compared with mice on WTD + PSE; however, this effect did not
reach statistical significance (Figure 4E and F).
3.5 Effects of plant sterols and plant stanols
on endothelial function
Analysis of aortic rings showed that endothelial-dependent vasore-
laxation was impaired in mice fed the WTD + PSE and WTD +
PSA diets compared with mice fed the WTD (P, 0.05).
Endothelial-independent vasorelaxation in response to nitroglycerin
was equal in all three groups (Figures 5A and 4B).
3.6 Effects of PSE and PSA on the
development of atherosclerosis
After the 6 weeks of treatment with specific diets, the mice were
sacrificed, aortas were excised, and the aortic lesion area was quanti-
fied by histomorphometric analysis. Atherosclerotic lesion formation
was most pronounced in mice on the WTD, in which atherosclerotic
lesions covered 28.3+3.5% of the luminal area in the aortic root. PSE
supplementation reduced atherosclerotic lesions; however, this effect
did not reach significance (17.5+3.7 vs. 28.3+3.5% in the WTD +
PSE group compared with the WTD group, respectively). The effect
on atherosclerotic lesion reduction was more pronounced in
response to PSA supplementation (12.7+ 3.7 vs. 28.3+3.5% in
the WTD + PSA group compared with the WTD group, respectively;
Figure 4 Effects of dietary PSA and PSE on inflammatory cytokines in aortic tissue, in plasma, and in circulating monocytes. Effect on IL-6 mRNA
expression in aortic tissue. *P, 0.05 for WTD + PSA vs. WTD and WTD + PSE. Effect on TNF-a and (C) IL-6 in plasma. #P, 0.05 for WTD + PSA
vs. WTD. Effect on IL-6, (E) IL-1b, and (F ) MCP-1 in circulating monocytes. §P, 0.05 for WTD + PSA vs. WTD.
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P, 0.05). However, no significant difference between the two groups
with supplemented diets was observed (Figure 5C and D).
3.7 Histological characterization of
atherosclerotic lesions in apoE2/2 mice
on PSE and PSA
In all groups, macrophages localized mostly in the shoulder region of
plaques and in the area surrounding the lipid core. Cholesterol low-
ering reduced macrophage infiltration. Intimal SMC content was less
pronounced in WTD animals compared with animals on cholesterol-
lowering therapy, and mice on WTD + PSE were characterized by
increased infiltration of L6-C(high) macrophages compared with
WTD- and WTD + PSA-fed animals. There was no difference in
regard to lipid accumulation within atherosclerotic lesions between
the groups (Figure 5C, E, and F ).
3.8 Effects of PSE and PSA on tissue sterol
concentrations
Concentrations of plant stanol and plant sterol in the liver and brain of
the three groups of apoE2/2 mice were assessed. The average hepatic
cholesterol concentration in the group fed the WTD was 16.2+
0.8 mg/mg. Diet supplementation with PSA reduced hepatic cholesterol
concentrations by 43% (to 9.2+0.8 mg/mg), but increased hepatic
plant stanol concentrations 48-fold (0.44+ 0.06 vs. 21.31+3.37 ng/
mg for campestanol; P, 0.0005). PSE supplementation caused a 46%
reduction in hepatic cholesterol concentrations (to 8.7+ 0.6 mg/mg),
but increased hepatic plant sterol concentrations 28-fold (11.65+
Figure 5 Effects of dietary PSA and PSE on endothelial function and atherosclerosis. Functional performance of isolated aortic segments was
assessed in organ chamber experiments. (A) Endothelium-dependent vasorelaxation induced by carbachol and (B) endothelial-independent vasore-
laxation induced by nitroglycerin (NTG), expressed as a percent of maximal phenylephrine-induced vasoconstriction. Values are mean+ SEM
(n ¼ 10 per group). #P, 0.05 for WTD (black) vs. WTD + PSA (dark grey) and WTD + PSE (bright grey). Atherosclerotic lesion formation in
the aortic sinus of apoE2/2 mice on a high-cholesterol WTD, WTD with PSA supplementation, and WTD with PSE supplementation. (C) Repre-
sentative examples (oil-red-O), bars: 500 mm (D) histomorphological analysis, (E) representative atherosclerotic lesions: macrophages (MAC,
MOMO-2), vascular SMC (a-actin), and Ly-6C monocytes. Bars: 100 mm. (F ) Semi-quantitative grading of stainings: (+) weak staining, (++) mod-
erate staining, and (+++) intense staining. Values are mean+ SEM (n ¼ 10 per group). *P, 0.05 for WTD + PSA vs. WTD.
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0.85 vs. 315.16+23.80 ng/mg for campesterol; P, 0.0005) (Figure 6A).
Supplementation with PSA or PSE had no effect on cholesterol concen-
trations in the brain (Figure 6B). However, PSA supplementation
increased plant stanol concentrations in the brain 2.9-fold (0.73+
0.03 vs. 2.16+0.33 ng/mg for campestanol; P, 0.0005), whereas sup-
plementation with PSE increased plant sterol concentrations in the
brain 1.8-fold (62.64+ 1.86 vs. 110.71+ 3.33 ng/mg for campesterol;
P, 0.0005). Of note, supplementation with PSE increased absolute
plant sterol concentrations in the brain 51-fold compared with PSA
(2.16+0.33 vs. 110.71+ 4.82 ng/mg), with a more pronounced
impact on brain tissue sterol composition (Figure 6B).
4. Discussion
The major and novel finding of this study is an increase in a
‘pro-atherogenic’ monocyte subpopulation and a less pronounced
atherosclerotic lesion reduction in mice fed a diet supplemented
with PSE compared with PSA, despite a similar reduction in plasma
cholesterol. Mice on a diet supplemented with PSA demonstrated a
more pronounced reduction in inflammatory cytokines in aortic
tissue, in plasma, and in circulating monocytes, vascular superoxide
and lipid hydroperoxide production, an increase in ‘regenerative’
monocytes, and, due to their lower absorbability, lower plasma,
liver, and brain tissue concentrations of plant stanols.
We previously observed in apoE2/2 mice that a diet supplemented
with PSE (equivalent to a commercially available spread) induced endo-
thelial dysfunction and led to an increase in ischaemic stroke size in wild-
type mice.13 Moreover, we observed that inhibition of cholesterol
absorption by a diet supplementation with PSE was associated with
twice the amount of atherosclerotic lesion formation compared with
ezetimibe treatment (a drug that reduces both plasma cholesterol
and plant sterol levels), despite similar plasma cholesterol levels.
Thus, our previous study identified a positive correlation between
sterol concentrations and the extent of atherosclerotic lesions.
Figure 6 Effects of dietary PSA and PSE on sterol tissue concentrations. Effect of 6-week treatment of apoE2/2 mice with a high-cholesterol WTD
controls or supplemented with PSA or PSE on liver (A) and brain (B) cholesterol, campestanol, and campesterol concentrations. Values are
mean+ SEM (n ¼ 10 per group). (A) *P, 0.05 for WTD vs. WTD + PSA and WTD + PSE; #P, 0.05 for WTD + PSE vs. WTD and
WTD + PSA; §P, 0.05 for WTD + PSA vs. WTD and WTD + PSA. (B) *P, 0.05 for WTD + PSE vs. WTD and WTD + PSA; #P, 0.05 for
WTD + PSA vs. WTD and WTD + PSE.
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Other groups previously demonstrated the involvement of plant
sterols in macrophage apoptosis and suggested a potential mechanism
for a possible pro-atherosclerotic effect of plant sterols.14 Further-
more, it has been shown that the Ly-6C(high) subset is dramatically
increased among monocytes in hypercholesterolaemic apoE2/2
mice consuming a high-cholesterol WTD.15 On the basis of these
data, we speculated that a diet supplementation with PSA and PSE
would differentially affect the expression of monocyte subpopulations,
consequently impacting endothelial function and atherosclerosis.
It has been previously demonstrated that a diet supplementation
with plant sterols compared with plant stanols in mice results in a
slightly, however, not statistically significant more pronounced
reduction in plasma cholesterol levels.16 The data of this study are
in line with these findings and demonstrate that even though plasma
cholesterol lowering with PSE in mice was slightly more effective
compared with PSA, PSE-fed mice exhibited a significant increase in
inflammatory Ly-6C(high) monocyte numbers. In contrast, the
Ly-6C2 population, which appears to have immunomodulatory
tasks,17 is significantly elevated in animals fed with PSA. Therefore,
it can be speculated that compared with stanols, plant sterols have
an additive inflammatory impact that may contribute to atherosclero-
sis. This hypothesis is further supported by a more pronounced
reduction in vascular superoxide and lipid hydroperoxide production
by a diet supplementation with PSA as well as by a more pronounced
reduction in inflammatory cytokines in aortic tissue, in plasma, and in
circulating monocytes. In previous studies, we and others have
observed a prominent role of the NADPH oxidase system for lipid-
mediated changes of vascular oxidative stress; therefore, NADPH
oxidase activity was assessed here. However, the data suggest that
NADPH oxidase is not the most important regulator in this specific
context. Other potential sources of superoxide include mitochondrial
respiration, as well as enzymes such as xanthine oxidase. In addition,
the quantity of O2
2 is determined by superoxide-scavenging enzymes,
most importantly superoxide dismutase. In the present study, the
important finding is the differential regulation of superoxide and
lipid hydroperoxides by plant sterols and plant stanols. Clearly,
these data set the stage for future studies to clarify the effects of
sterols and stanols on vascular oxidative stress in more detail.
Only recently, it has been demonstrated that monocytes are cellu-
lar protagonists of tissue repair and their specific subtypes are
involved in the healing programme after myocardial infarction.18
Panizzi et al. found in apoE2/2 mice that Ly-6C(high) monocytes
dominate on days 1–4 and digest damaged tissue, whereas reparative
Ly-6C2 monocytes dominate on days 5–10 and promote angiogen-
esis and scar formation. Moreover, Panizzi et al. demonstrated that
Ly-6C(high) monocytes impair infarct healing through prolonged
presence in the infarct and de-regulated resolution of inflammation.
Of note, statin treatment of atherosclerotic apoE2/2mice has
been shown to reduce Ly-6C(high) monocyte counts.17 These find-
ings underscore the potential importance of monocyte subpopu-
lations in apoE2/2mice.
Although both supplementations reduced atherosclerotic lesion
development in the aortic root in apoE2/2 mice, plant stanols had
a more pronounced effect. This may result from the two-fold
higher numbers of Ly-6C2 monocytes found in PSA-fed mice.
However, higher numbers of this monocyte subtype apparently do
not have enough regenerative power to overcome the enormous
atherosclerotic burden in apoE knockout mice. Interestingly, despite
the reduction in plasma cholesterol concentrations by plant stanols
and plant sterols, endothelial function was impaired in these groups
compared with controls. This finding is consistent with previous
data obtained in wild-type mice on a diet supplemented with PSE,13
but so far unexplained for mice on a diet supplemented by PSA. A
possible, although speculative, notion is that increased lymphocyte
numbers are associated with impairment in endothelial function
under these conditions. However, as our study did not include lym-
phocyte analysis, no detailed information is available regarding these
different lymphocyte subsets in animals fed on PSE and PSA sup-
plemented diets. Therefore, further research will be required.
Our data contribute to the notion that phytosterols may not confer
positive effects during atherogenesis. In fact, patients with phytoster-
olaemia, a rare autosomal-recessive disease, show an increase in plant
sterol plasma concentrations by more than 30-fold, caused by a defect
in the ABCG5 or ABCG8 transporter genes. In these individuals, elev-
ated plant sterol levels are associated with a malignant premature
atherosclerosis.19,20 The second line of evidence stems from several
concurrent epidemiological studies, suggesting that upper normal
plasma concentrations of plant sterols are associated with increased
risk of cardiovascular events.21– 26 Only recently, data from the
KORA study revealed that common variants in ABCG8 in the
normal population were strongly related to elevated serum plant
sterol levels and increased risk for coronary artery disease, whereas
ABCG8 genotypes associated with decreased serum plant sterol
levels were associated with a reduced risk of coronary artery
disease.27 These findings have stimulated the discussion that plant
sterols, which are also used as markers of cholesterol absorption,
might be involved in the pathogenesis of atherosclerosis.6,7,28 Regard-
ing potential molecular mechanisms, one possibility is that plant
sterols are more readily oxidized than cholesterol and that especially
oxysterols affect the cardiovascular risk.29,30 Data presented in this
study demonstrating a difference between PSA and PSE on vascular
superoxide production and lipid hydroperoxides further add to this
notion.
We previously showed that a diet supplementation with PSE in
humans leads to increased plant sterol concentrations in plasma and
in aortic valve cusps.13 Therefore, another aim of this study was to
determine the deposition of plant stanols and plant sterols in
various organ tissues. Our data demonstrate for the first time that
in apoE2/2 mice, plant stanols and plant sterols are incorporated
in both hepatic and cerebral tissues. Interestingly, in a similar study
in apoE*3-Leiden mice, Plat et al.31 reported that a diet supplemen-
tation with plant stanols and plant sterols increased concentrations
in various tissues; however, no increase was observed in liver and in
brain tissue. Similarly, Jansen et al.32 reported that diet supplemen-
tation of apoE2/2mice with plant sterols did not increase plant
sterol concentrations in the brain tissues. Since plant sterols accumu-
late in the brain of wild-type mice, the authors speculated that apoE is
required as a chaperone protein to facilitate sterol transport over the
blood–brain barrier. The findings of our study do not support this
hypothesis. One potential explanation for these contradictory findings
is the difference in the experimental diets. Both Plat et al. and Jansen
et al. used a low-cholesterol diet [0.25 and 0.12% (w/w) respectively],
whereas in our study, mice were fed a 1.25% (w/w) cholesterol-
enriched diet. Therefore, our findings suggest that in the absence of
apoE, an increase in cholesterol facilitates both plant stanol and
plant sterol accumulation in the brain. Drevets et al. previously
demonstrated that Ly-6C monocytes function in the transport of Lis-
teria monocytogenes over the blood–brain barrier, establishing their
O. Weinga¨rtner et al.Page 8 of 9
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role as Trojan horses in vivo.33 Thus, another possible explanation is
that an increase in Ly-6C(high) monocytes facilitates plant sterol
transport over the blood–brain barrier. Further research is required
to fully address this hypothesis.
The findings from our experimental study are of potential clinical
importance, as plant stanols and plant sterols incorporated in
tissues may potentially cause adverse effects. For example, sitostero-
laemic patients are known to have anaemic episodes, probably related
to disturbed red blood cell characteristics.19 In fact, in SPHR rats,
which are characterized by increased plant sterol concentrations
from a defect in ABCG5, high plant sterols were associated with
increased stroke risk, which was ascribed to reduced erythrocyte
deformability.34 Furthermore, Yang et al.35 demonstrated that a
severe accumulation of plant sterols in the adrenals of ABCG5/
82/2 mice was associated with depletion of cholesteryl esters,
further adding to the notion that a diet supplementation with plant
sterols potentially interferes with the hormonal system.
In summary, dietary supplementation with both PSA and PSE
reduced plasma cholesterol concentrations in apoE2/2 mice. Mice
on a diet supplemented with PSE demonstrated an increase in a
‘pro-atherogenic’ monocyte subpopulation and a less pronounced
atherosclerotic lesion reduction. Furthermore, mice on a diet sup-
plemented with PSE showed increased vascular superoxide and lipid
hydroperoxide production and, due to enhanced absorbability,
higher plasma concentrations and increased plant sterol tissue depo-
sition in major organ systems.
These findings underline the need for clinical studies that evaluate
not only the effectiveness of serum cholesterol reduction, but also
the clinical effects and safety of a diet supplementation with PSE.
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